CGFAX
Price
$86.04
Change
+$0.47 (+0.55%)
Updated
Sep 11 closing price
Net Assets
353.07B
WPASX
Price
$47.57
Change
+$0.76 (+1.62%)
Updated
Sep 11 closing price
Net Assets
421.64M
Interact to see
Advertisement

CGFAX vs WPASX

CGFAX vs WPASX Comparison Chart in %
View a ticker or compare two or three
VS
CGFAX vs. WPASX commentary
Sep 13, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CGFAX is a Buy and WPASX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CGFAX has more cash in the bank: 353B vs. WPASX (422M). CGFAX pays higher dividends than WPASX: CGFAX (0.23) vs WPASX (0.00). CGFAX was incepted earlier than WPASX: CGFAX (25 years) vs WPASX (13 years). WPASX (1.00) is less costly to investors than CGFAX (0.62). CGFAX is a more actively managed with annual turnover of: 32.00 vs. WPASX (18.00). WPASX initial investment is less costly to investors than CGFAX (4%) vs CGFAX (4%). CGFAX has a lower initial minimum investment than WPASX: CGFAX (250) vs WPASX (2500). CGFAX annual gain was more profitable for investors over the last year : -0.03 vs. WPASX (-15.44). CGFAX return over 5 years is better than : 13.11 vs. WPASX (-23.32).
CGFAXWPASXCGFAX / WPASX
Total Expense Ratio0.621.0062%
Annual Report Gross Expense Ratio0.621.0062%
Fund Existence25 years13 years-
Gain YTD9.063-6.268-145%
Front Load4%4%82%
Min. Initial Investment250250010%
Min. Initial Investment IRAN/AN/A-
Net Assets353B422M83,649%
Annual Yield % from dividends0.230.00-
Returns for 1 year-0.03-15.440%
Returns for 3 years42.54-3.84-1,107%
Returns for 5 years13.11-23.32-56%
Returns for 10 years110.8370.15158%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NAMS22.800.94
+4.30%
NewAmsterdam Pharma Company NV
BYRN3.620.09
+2.55%
Byrna Technologies
CX10.690.03
+0.28%
Cemex SAB de CV
RGNX8.53-0.03
-0.35%
REGENXBIO
CRIS1.13-0.03
-2.59%
Curis Inc.